tiprankstipranks
Advertisement

TNXT - ETF AI Analysis

Compare

Top Page

TNXT

T. Rowe Price Innovation Leaders ETF (TNXT)

Rating:70Outperform
Price Target:
TNXT, the T. Rowe Price Innovation Leaders ETF, earns a solid overall rating thanks to heavy exposure to innovation leaders like Alphabet, Microsoft, Apple, Nvidia, and Broadcom, which all benefit from strong financial performance and long-term growth potential in AI, cloud, and advanced semiconductors. These high-quality tech and AI names are the main drivers of the fund’s quality, while weaker spots like Intel and Eli Lilly, which face valuation and cash flow or leverage challenges, modestly hold back the rating. The main risk is the fund’s concentration in a narrow group of large technology and AI-focused companies, which can increase volatility if that sector falls out of favor.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the year to date and in the last three months, indicating positive recent momentum.
Leading Innovation Holdings
Many of the top positions, including major technology and healthcare innovators, have delivered strong or very strong performance, helping drive the fund’s returns.
Sector Diversification Within Growth Areas
While tilted toward technology and health care, the fund also holds communication services, financials, consumer, and industrial stocks, spreading risk across several growth-oriented sectors.
Negative Factors
High Technology Concentration
Nearly half of the portfolio is in technology stocks, which can make the ETF more sensitive to downturns in the tech sector.
Heavy U.S. Market Focus
With the vast majority of assets in U.S. companies, the fund offers limited geographic diversification and is closely tied to the U.S. market’s fortunes.
Moderate Expense Ratio
The fund’s expense ratio is higher than many broad, low-cost index ETFs, which can slightly reduce net returns over time.

TNXT vs. SPDR S&P 500 ETF (SPY)

TNXT Summary

The T. Rowe Price Innovation Leaders ETF (TNXT) is an actively managed fund that focuses on companies leading the way in new technology, products, and business models, mainly in the U.S. It doesn’t track a set index, but instead looks across the whole stock market for innovators, especially in technology and healthcare. Well-known holdings include Nvidia and Apple. Someone might invest in this ETF to seek long-term growth by backing companies shaping the future economy. A key risk is that it is heavily tilted toward fast-growing tech-related stocks, so its price can be more volatile and can go up and down sharply.
How much will it cost me?This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because this fund is actively managed and focuses on specialized innovation leaders, which typically costs more to run.
What would affect this ETF?This ETF is heavily invested in innovative technology and healthcare companies like Nvidia, Apple, and Eli Lilly, so it could benefit if new breakthroughs in areas such as artificial intelligence, cloud computing, and medical treatments continue and if interest rates stabilize or fall, which often supports growth-focused stocks. On the other hand, it could be hurt by higher interest rates, stricter tech or healthcare regulations, slower economic growth in developed markets, or a shift in investor preference away from fast-growing companies toward more defensive or value-oriented sectors.

TNXT Top 10 Holdings

TNXT is leaning hard into U.S. innovation, with a clear tech-and-AI backbone. Nvidia, AMD, and Broadcom are the main engines here: despite some recent bumps for Nvidia and Broadcom, their longer-term climb in AI chips is still doing much of the heavy lifting. Intel has surprisingly joined the winners’ circle lately, adding extra spark. Apple and Amazon look more mixed, cooling off in the near term after earlier gains, while Microsoft has been losing a bit of steam, slightly dragging on the fund’s otherwise growthy tilt.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Nvidia7.85%$1.39M$5.14T43.91%
76
Outperform
Apple4.83%$855.17K$4.35T52.95%
79
Outperform
Amazon3.26%$576.18K$2.65T14.51%
71
Outperform
Broadcom3.14%$555.85K$1.87T51.06%
76
Outperform
Microsoft2.93%$518.09K$2.97T-17.62%
79
Outperform
Alphabet Class A2.67%$472.40K$4.46T112.13%
85
Outperform
Advanced Micro Devices2.52%$445.47K$892.36B299.13%
73
Outperform
Alphabet Class C2.38%$421.81K$4.46T109.39%
82
Outperform
Eli Lilly & Co2.03%$359.13K$1.06T41.86%
72
Outperform
Intel2.01%$356.60K$642.62B462.74%
64
Neutral

TNXT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
26.18
Positive
100DMA
200DMA
Market Momentum
MACD
0.22
Positive
RSI
58.52
Neutral
STOCH
76.27
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TNXT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.03, equal to the 50-day MA of 26.18, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.22 indicates Positive momentum. The RSI at 58.52 is Neutral, neither overbought nor oversold. The STOCH value of 76.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TNXT.

TNXT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$17.54M0.49%
70
Outperform
$233.16M0.50%
71
Outperform
$87.32M0.45%
68
Neutral
$43.59M0.78%
64
Neutral
$17.19M1.27%
62
Neutral
$16.89M0.80%
62
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TNXT
T. Rowe Price Innovation Leaders ETF
27.41
2.90
11.83%
GDIV
Harbor Dividend Growth Leaders ETF
INEQ
Columbia International Equity Income Etf
KNO
AXS Knowledge Leaders ETF
RW
Rainwater Equity ETF
HDMV
First Trust Horizon Managed Volatility Developed Intl ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement